On the consensus nomenclature rules for radiopharmaceutical chemistry - Reconsideration of radiochemical conversion.

Consensus guidelines Nomenclature Nuclear chemistry Radiochemical conversion Radiochemical yield Radiochemistry Radiopharmaceutical sciences Terminology

Journal

Nuclear medicine and biology
ISSN: 1872-9614
Titre abrégé: Nucl Med Biol
Pays: United States
ID NLM: 9304420

Informations de publication

Date de publication:
02 2021
Historique:
received: 16 04 2020
accepted: 11 11 2020
pubmed: 25 11 2020
medline: 12 3 2021
entrez: 24 11 2020
Statut: ppublish

Résumé

Radiochemical conversion is an important term to be included in the "Consensus nomenclature rules for radiopharmaceutical chemistry". Radiochemical conversion should be used to define reaction efficiency by measuring the transformation of components in a crude reaction mixture at a given time, whereas radiochemical yield is better suited to define the efficiency of an entire reaction process including, for example, separation, isolation, filtration, and formulation.

Identifiants

pubmed: 33232876
pii: S0969-8051(20)30288-2
doi: 10.1016/j.nucmedbio.2020.11.003
pii:
doi:

Substances chimiques

Radiopharmaceuticals 0

Types de publication

Letter Comment

Langues

eng

Sous-ensembles de citation

IM

Pagination

19-21

Commentaires et corrections

Type : CommentOn
Type : CommentOn

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Matthias M Herth (MM)

Department of Drug Design and Pharmacology, University of Copenhagen, Jagtvej 160, 2100 Copenhagen, Denmark; Department of Clinical Physiology, Nuclear Medicine & PET, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark. Electronic address: matthias.herth@sund.ku.dk.

Simon Ametamey (S)

Department of Chemistry and Applied Biosciences, ETH Zurich, Vladimir-Prelog-Weg 1-5/10, 8093 Zürich, Switzerland.

Dmitrii Antuganov (D)

Almazov Northwest Federal Medical Research Center, Ministry of Health of the Russian Federation, ul. Akkuratova 2, St. Petersburg 197341, Russia.

Andreas Bauman (A)

Clinic of Radiology and Nuclear Medicine, University of Basel Hospital, Petersgraben 4, CH-4031 Basel, Switzerland.

Mathias Berndt (M)

Life Molecular Imaging GmbH, Tegeler Str. 6-7, D-13353 Berlin, Germany.

Allen F Brooks (AF)

Department of Radiology, University of Michigan Medical School, 1301 Catherine St, Ann Arbor, MI 48109, USA.

Guy Bormans (G)

Laboratory for Radiopharmaceutical Research, KU Leuven, Herestraat 49, box 821, 3000 Leuven, Belgium.

Yearn Seong Choe (YS)

Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, Republic of Korea.

Nic Gillings (N)

Department of Clinical Physiology, Nuclear Medicine & PET, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark.

Urs O Häfeli (UO)

Faculty of Pharmaceutical Sciences, University of British Columbia, 2405 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.

Michelle L James (ML)

Department of Radiology and Department of Neurology and Neurological Sciences Molecular Imaging Program at Stanford (MIPS), Stanford University School of Medicine, 1201 Welch Road, P-206, Stanford, CA 94305, USA.

Klaus Kopka (K)

Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Bautzner Landstraße 400, D-01328 Dresden, Germany.

Vasko Kramer (V)

Positronpharma SA, Providencia, 7500921 Santiago, Chile.

Raisa Krasikova (R)

N.P. Bechtereva Institute of Human Brain, Russian Academy of Science, Laboratory of Radiochemistry, 9 Ak. Pavlova St., 197376 St. Petersburg, Russia.

Jacob Madsen (J)

Department of Clinical Physiology, Nuclear Medicine & PET, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark.

Linjing Mu (L)

Department of Chemistry and Applied Biosciences, ETH Zurich, Vladimir-Prelog-Weg 1-5/10, 8093 Zürich, Switzerland.

Bernd Neumaier (B)

Institute of Neuroscience and Medicine, Forschungszentrum Jülich, D-52425 Jülich, Germany.

Markus Piel (M)

Department of Chemistry, Johannes Gutenberg-Universität Mainz, Fritz-Strassmann-Weg 2, D-55128 Mainz, Germany.

Frank Rösch (F)

Department of Chemistry, Johannes Gutenberg-Universität Mainz, Fritz-Strassmann-Weg 2, D-55128 Mainz, Germany.

Tobias Ross (T)

Department of Nuclear Medicine, Hannover Medical School, Carl-Neuberg-Straße 1, D-30625 Hannover, Germany.

Roger Schibli (R)

Department of Chemistry and Applied Biosciences, ETH Zurich, Vladimir-Prelog-Weg 1-5/10, 8093 Zürich, Switzerland.

Peter J H Scott (PJH)

Department of Radiology, University of Michigan Medical School, 1301 Catherine St, Ann Arbor, MI 48109, USA.

Vladimir Shalgunov (V)

Department of Drug Design and Pharmacology, University of Copenhagen, Jagtvej 160, 2100 Copenhagen, Denmark.

Neil Vasdev (N)

Azrieli Centre for Neuro-Radiochemistry, Brain Health Imaging Centre, Centre for Addiction and Mental Health & Department of Psychiatry, University of Toronto, 250 College St., Toronto M5T-1R8, ON, Canada.

Wolfgang Wadsak (W)

Department of Biomedical Imaging und Image-guided Therapy, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.

Brian M Zeglis (BM)

Department of Chemistry, Hunter College of the City University of New York, New York, NY, USA; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Articles similaires

Humans Hepatectomy Male Female Retrospective Studies
Cryoelectron Microscopy Algorithms Image Processing, Computer-Assisted Consensus Software

Anhui Zhu, Xiaoyan Hou, Na Guo et al.
1.00
Humans Carcinoma, Renal Cell Vena Cava, Inferior Male Female
Humans Pilot Projects Delphi Technique Consensus Congresses as Topic

Classifications MeSH